DEF 14A

Company

CNS Pharmaceuticals, Inc.

Filed

October 24, 2025

Period of Report

November 17, 2025

Accession Number

0001683168-25-007760

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →